CooperVision products

我們的產品

CooperVision 知道每隻眼睛都不一樣。而隱形眼鏡的佩戴者亦然。我們擁有種類最廣泛的軟性隱形眼鏡*1，很榮幸能為您提供最優越的選擇，滿足您獨特的需要。

我們提供全面的每日即棄和可重複使用（每兩星期或每月即棄）隱形眼鏡，以滿足任何生活方式、預算和視力矯正需要。無論您的預算有限但拒絕就品質妥協，或正在尋找具備最新功能的優質隱形眼鏡，我們都能滿足您的需求。

* Based on Rx option combinations (sphere, cylinder, axis and add) manufactured, across all soft lenses in sphere, toric and multifocal (including made to order), in SiHy and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic and Photochromatic contact lenses not included. Multiple base curve variants not included.

† Compared among CooperVision 1 day silicone hydrogel contact lenses. Data on file.

‡ Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.

§ Based on subjective ratings at insertion and after 1 month. Results of a prospective, double-masked, randomised, bilateral, crossover study comparing Avaira Vitality™ sphere contact lenses with a competitive reusable sphere lens.

‖ compared to a single vision 1 day lens over a 3 year period

References:

1. CVI data on file, 2019.

2. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. (2019);96 (8):556–567.

3. Cavet ME, et al. In vitro biocompatibility assessment of multipurpose contact lens solutions: Effects on human corneal epithelial viability and barrier function. Contact Lens and Anterior Eye. (2012);35 (4):163-170.

4. Griffiths H. Clinical performance of the Bioclear family of lenses. Optician. 2008 (3).

5. Bloomenstein MR. Differentiating the stain: What does it all mean? 2012. PDF file.

6. CVI data on file, 1997, 1999, 2000, 2008, 2011, 2018.

7. Wu G, et al. Lipid corralling and poloxamer squeeze-out in membranes. Phys. Rev. Lett. 2004;93:028101–028104.

8. Wu G, et al. Interaction between lipid monolayers and poloxamer 188: an X-ray reflectivity and diffraction study. Biophys J. 2005; 89:3159–3173.

9. CVI data on file, 1997, 1999, 2000, 2008, 2011, 2018

10. CVI data on file 2011.

11. CVI data on file 2018: Short-term (2 hour) clinical evaluation with 28 subjects wearing fanfilcon A or comfilcon A, both CLs having been soaked overnight in AIOL.

12. CVI data on file 2012.

13. Goa L, Benfield P. Hyaluronic acid: a review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs (1994);47 (3):536-566.

14. CVI data on file, 2001.

15. CVI data on file, 1998 and 2012

16. CVI data on file.

17. CVI data on file, 2008.

18. CVI data on file, 1997.

19. Kim HL, et al. Modulation of protein adsorption by poloxamer 188 in relation to polysorbates 80 and 20 at solid surfaces. J Pharm Sci. (2014);103 (4):1043–1049.

20. Coopervision data on file 1999.

21. Rasyid NQ, et al. Suspension stability and characterization of chitosan nanoparticle–coated ketoprofen based on surfactants oleic acid and poloxamer 188. Makara J. Sci. (2014);18 (3):86-90.

22. Vibhute S, et al. Formulation and evaluation of tear substitutes. Int J Pharm Sci Rev Res. 2010;2 (1).

23. Doughty MJ. Re-wetting, comfort, lubricant and moisturizing solutions for the contact lens wearer. Contact Lens and Anterior Eye (1999); 22 (4):116-126.

24. Chiu G. Care and compliance in contact lens success. AOA Contact Lens and Cornea Section. 2009 Research paper.